Fundraising FoxCellCo
3 known investors
Find your way into CellCo
Sign up to find every way you can get introduced to CellCo
- Your email: who you already know at CellCo, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the CellCo team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
CellCo applies computational simulation, generative AI, and medicinal chemistry to design glycan-enabled therapeutics, engineering glycan ligands that direct RNA, small molecules, and antibodies to specific tissues and cell types. It develops platforms for molecular dynamics, synthetic data generation, and foundation models targeting glycan chemistry, immune modulation, and targeted drug delivery.
Investors · 3
Frequently asked questions
- What does CellCo do?
- CellCo applies computational simulation, generative AI, and medicinal chemistry to design glycan-enabled therapeutics, engineering glycan ligands that direct RNA, small molecules, and antibodies to specific tissues and cell types. It develops platforms for molecular dynamics, synthetic data generation, and foundation models targeting glycan chemistry, immune modulation, and targeted drug delivery.
- Who are CellCo's investors?
- CellCo's investors include AIR Capital, Draper Associates, Spacecadet Ventures.